Biotechnology and Bioethics in Islamic Iran: Policy Review
This paper examines the intersection of biotechnology and bioethics within the Islamic Republic of Iran, situating Iran's scientific developments within broader Islamic jurisprudence and global bioethical frameworks. It traces the historical background of biomedical ethics regulations — from the Nuremberg Code to CIOMS guidelines — and considers how Iran's Shia Islamic tradition shapes permissible biotechnology practices, particularly in stem cell research and agricultural development. A SWOT analysis evaluates the strengths, weaknesses, opportunities, and threats facing biotechnology in Iran and the broader Middle East. The paper concludes with ethical recommendations grounded in Islamic values and calls for expanded international cooperation, national capacity-building, and culturally adapted bioethical guidelines.
- Executive Summary: Global biotechnology's impact and Islamic nations' needs
- Introduction: Bioethics and biotechnology debates in Islamic Iran
- Background of the Problem: Historical bioethics regulations and Iran's scientific rise
- Policy Options and Evaluation Criteria: Islamic and Shia legal foundations for bioethical policy
- Policy Choices and SWOT Analysis: Strengths, weaknesses, opportunities, and threats assessed
- Ethical Recommendations: Guidelines for culturally adapted biotechnology research ethics
- Conclusion: Call for education, cooperation, and legal reform
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds the discussion of modern biotechnology in a culturally specific religious and legal context, showing how Shia Islamic jurisprudence actively shapes science policy in Iran.
- Uses a SWOT framework to organize policy analysis systematically, making abstract ethical and regulatory concerns concrete and comparable.
- Bridges international bioethics standards (Nuremberg Code, CIOMS, Helsinki Declaration) with locally adapted Iranian codes, illustrating how global frameworks are negotiated at the national level.
Key academic technique demonstrated
The paper demonstrates policy analysis integrated with comparative religious ethics. By examining both Sunni and Shia sources alongside secular international bioethics documents, it models how to synthesize multiple normative frameworks — religious, legal, and scientific — to evaluate a single policy domain. This comparative approach strengthens the argument for culturally adapted guidelines rather than universal mandates.
Structure breakdown
The paper opens with an executive summary covering the global landscape, then narrows to Iran in the introduction. The background section traces relevant regulatory history and Iran's scientific development. The policy options section explores Islamic and Shia legal foundations for bioethics. A SWOT analysis follows, assessing practical strengths, weaknesses, opportunities, and threats. Ethical recommendations and a brief conclusion round out the paper, keeping the focus on actionable policy suggestions grounded in Iranian Islamic values.
Executive Summary
Contemporary biotechnology has made considerable contributions to the global agriculture and health sectors. The development of medicines, pharmaceuticals, and vaccines using recombinant DNA technology has made biotechnology a multibillion-dollar global industry. Additionally, PCR-based diagnostics have emerged as a crucial element of the health industry. Because the vast majority of Islamic nations have economies centered on agriculture, biotechnology holds enormous potential to improve efficiency in these countries.
The demand for food in Islamic nations over the past two decades is predicted to increase by nearly half. That increase will have to come through improvements in agricultural efficiency in marginal, fertile, salt-affected, and rainfed areas. There will likely be less workforce, arable land, and water available to the agriculture sector. This scenario results from a declining rural population, poor management of water reserves and supplies, environmental degradation and infertility, and above all, rising populations. To meet these challenges, technologies such as biotechnology must be applied to address many of these problems.
Exposure of farmers to biotechnological education could cultivate an appreciation of biotechnology for growth and development. Capacity-development schemes and programs could go a long way toward resolving uncertainties about the use of biotechnology across a range of sectors. Capacity development — for example, in the acquisition and use of GMOs in agriculture, field trials, and the assessment of environmental and human impact — could generate responses more favorable than those currently produced by a lack of training.
Through national capacity-building programs, international cooperation, and regional networks, developing nations can harness the potential of biotechnology as a valuable instrument for addressing hunger, illness, and poverty. Gradual advancement and demonstrated successes will bear out the long-term benefits of biotechnology for national economic progress and development. It is also time for developing nations to be more proactive in identifying their unique strengths, weaknesses, and competencies, and in setting the agenda and pace for applying biotechnology to their own scientific and national development plans. Ethical recommendations for conducting biotechnology research include well-designed studies, appropriate cooperation with ethics commissions, and respect for the rights of research subjects, both animal and human.
Introduction
Significant advances in biomedical technologies — including gamete and stem cell research, genetic testing, and embryo donation and therapy — have prompted a reclassification of what constitutes life. In the developed world, the ethical and emotional debates surrounding these technologies have been substantial. Within Muslim communities, the response has been equally fraught with religious and moral concerns, and a comparable absence of consensus. Fatwas (religious decrees) on these contemporary debates vary among distinct Islamic schools of thought; these rulings in practice reflect local customs, national contexts, and moral traditions. Marcia Inhorn's (2010) analysis comparing Shia and Sunni approaches to gamete donation and infertility treatment in Lebanon and Egypt highlighted how differing Islamic understandings of what is permissible shape government reproductive policies and clinical practices.
This paper discusses biotechnology and bioethics in the Islamic Republic of Iran. It reviews the state of bioethics and biotechnology in Iran and offers policy recommendations.
References
Chyba, C. F. (2006). Biotechnology and the challenge to arms control. Arms Control Today, 36(8), 11.
DaSilva, E. J., Baydoun, E., & Badran, A. (2002). Biotechnology and the developing world. Electronic Journal of Biotechnology, 5(1), 1–2.
Farajkhoda, T. (2017). An overview on ethical considerations in stem cell research in Iran and ethical recommendations: A review. International Journal of Reproductive BioMedicine, 15(2), 67.
Farajkhoda, T., Roudsari, R. L., & Abbasi, M. (2012). Ethical performance in delivery of sexual and reproductive health services: A Delphi study focused on the right of confidentiality. Health Med, 6, 3385–3394.
Inhorn, M. C., Patrizio, P., & Serour, G. I. (2010). Third-party reproductive assistance around the Mediterranean: comparing Sunni Egypt, Catholic Italy and multisectarian Lebanon. Reproductive BioMedicine Online, 21(7), 848–853.
Khodaparast, A. H., Abdolahzadeh, A., & Rasekh, M. (2008). A critical study of the "six ethical codes for research" in Iran. Journal of Reproduction & Infertility, 8(4).
King, N. M., & Perrin, J. (2014). Ethical issues in stem cell research and therapy. Stem Cell Research & Therapy, 5(4), 85.
Larijani, B., Zahedi, F., & Malek Afzali, H. (2005). Medical ethics in the Islamic Republic of Iran.
Create your account
Always verify citation format against your institution’s current style guide requirements.